Orbimed Advisors - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 37 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$26,809,131
-22.1%
9,308,726
+3.0%
0.57%
-8.8%
Q2 2023$34,418,496
+94.8%
9,033,726
-4.9%
0.62%
+79.8%
Q1 2023$17,665,860
-2.6%
9,497,774
+20.5%
0.35%0.0%
Q4 2022$18,135,201
-28.6%
7,884,8700.0%0.35%
-26.3%
Q3 2022$25,389,000
-41.5%
7,884,8700.0%0.47%
-40.1%
Q2 2022$43,367,000
+136.0%
7,884,8700.0%0.79%
+163.8%
Q1 2022$18,372,000
-61.4%
7,884,8700.0%0.30%
-51.3%
Q4 2021$47,625,000
-56.5%
7,884,8700.0%0.61%
-49.1%
Q3 2021$109,363,000
+6.7%
7,884,8700.0%1.20%
+15.9%
Q2 2021$102,503,000
-15.6%
7,884,8700.0%1.04%
-8.6%
Q1 2021$121,427,0007,884,8701.14%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 10,881,144$31,337,6953.43%
Sio Capital Management, LLC 2,081,216$5,993,9021.86%
Pivotal bioVenture Partners Investment Advisor LLC 1,375,000$3,960,0001.58%
TCG Crossover Management, LLC 3,038,889$8,752,0001.29%
Logos Global Management LP 2,525,000$7,272,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 1,531,497$4,410,7110.80%
Orbimed Advisors 9,308,726$26,809,1310.57%
GREAT POINT PARTNERS LLC 579,667$1,669,4410.30%
Temasek Holdings (Private) Ltd 9,901,940$28,517,5870.17%
TANG CAPITAL MANAGEMENT LLC 159,087$458,1710.06%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders